True Wealth Design’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.75K Sell
20
-43
-68% -$8.94K ﹤0.01% 1346
2026
Q1
$13.3K Buy
63
+41
+186% +$8.83K ﹤0.01% 871
2025
Q4
$4.52K Hold
22
﹤0.01% 1130
2025
Q3
$3.45K Hold
22
﹤0.01% 1237
2025
Q2
$3.7K Buy
22
+1
+5% +$148 ﹤0.01% 930
2025
Q1
$2.89K Buy
21
+11
+110% +$1.4K ﹤0.01% 877
2024
Q4
$1.18K Hold
10
﹤0.01% 887
2024
Q3
$1.11K Hold
10
﹤0.01% 949
2024
Q2
$984 Buy
10
+1
+11% +$102 ﹤0.01% 511
2024
Q1
$1.01K Buy
9
+3
+50% +$324 ﹤0.01% 465
2023
Q4
$605 Hold
6
﹤0.01% 429
2023
Q3
$521 Hold
6
﹤0.01% 420
2023
Q2
$568 Sell
6
-3
-33% -$253 ﹤0.01% 407
2023
Q1
$680 Hold
9
﹤0.01% 464
2022
Q4
$692 Buy
+9
New +$684 ﹤0.01% 390

Other funds holding CAH

True Wealth Design's CAH Position: Q2 2026 in Review

True Wealth Design reduced its Cardinal Health (CAH) stake by 68% in Q2 2026, selling an estimated $8.94K and leaving 20 shares worth $4.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1346.

True Wealth Design first reported a position in CAH in Q4 2022 and has held it in 15 quarters since. The position peaked at $13.3K in Q1 2026. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • True Wealth Design held 20 shares of Cardinal Health worth $4.75K as of Q2 2026.
  • True Wealth Design sold 43 Cardinal Health shares in Q2 2026, an estimated $8.94K.
  • Cardinal Health made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1346 holding.
  • True Wealth Design first reported a position in Cardinal Health in Q4 2022 and has held it in 15 quarters since.
  • True Wealth Design's Cardinal Health position peaked at $13.3K in Q1 2026.
  • 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.